Sg Americas Securities, LLC Regenxbio Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 10,375 shares of RGNX stock, worth $75,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,375

Previous 13,945 25.6%

Holding current value

$75,426

Previous $146,000 45.21%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$7.23 - $11.56 $25,811 - $41,269	-3,570 Reduced 25.6%	10,375 $80,000
Q3 2024 Oct 03, 2024	BUY	$10.49 - $14.39 $146,283 - $200,668	13,945 New	13,945 $146,000
Q4 2023 Jan 12, 2024	BUY	$12.89 - $20.82 $397,179 - $641,526	30,813 New	30,813 $553,000
Q4 2022 Feb 02, 2023	SELL	$20.4 - $24.73 $101,122 - $122,586	-4,957 Reduced 49.61%	5,035 $114,000
Q3 2022 Oct 31, 2022	SELL	$22.29 - $35.04 $471,166 - $740,675	-21,138 Reduced 67.9%	9,992 $264,000
Q2 2022 Jul 29, 2022	BUY	$19.35 - $35.04 $207,122 - $375,068	10,704 Added 52.4%	31,130 $769,000
Q1 2022 Apr 29, 2022	SELL	$24.62 - $34.31 $309,744 - $431,654	-12,581 Reduced 38.12%	20,426 $678,000
Q4 2021 Feb 07, 2022	SELL	$30.19 - $40.28 $21,495 - $28,679	-712 Reduced 2.11%	33,007 $1.08 Million
Q3 2021 Nov 01, 2021	BUY	$29.09 - $45.68 $980,885 - $1.54 Million	33,719 New	33,719 $1.41 Million
Q2 2021 Aug 12, 2021	SELL	$32.46 - $40.48 $682,731 - $851,415	-21,033 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $609,450 - $905,743	18,133 Added 625.28%	21,033 $717,000
Q4 2020 Feb 04, 2021	SELL	$26.52 - $49.35 $2.09 Million - $3.88 Million	-78,684 Reduced 96.45%	2,900 $132,000
Q3 2020 Nov 09, 2020	BUY	$27.01 - $40.26 $1.94 Million - $2.9 Million	71,974 Added 748.95%	81,584 $2.25 Million
Q2 2020 Jul 20, 2020	BUY	$27.75 - $43.44 $48,479 - $75,889	1,747 Added 22.22%	9,610 $354,000
Q1 2020 Apr 30, 2020	SELL	$21.5 - $54.2 $9,417 - $23,739	-438 Reduced 5.28%	7,863 $255,000
Q4 2019 Jan 28, 2020	SELL	$34.54 - $44.87 $1.58 Million - $2.06 Million	-45,822 Reduced 84.66%	8,301 $340,000
Q3 2019 Nov 04, 2019	BUY	$31.84 - $50.88 $1.37 Million - $2.19 Million	42,982 Added 385.8%	54,123 $1.93 Million
Q2 2019 Jul 29, 2019	SELL	$42.0 - $59.29 $7.06 Million - $9.97 Million	-168,138 Reduced 93.79%	11,141 $572,000
Q1 2019 Apr 29, 2019	BUY	$40.82 - $62.45 $6.92 Million - $10.6 Million	169,571 Added 1746.71%	179,279 $10.3 Million
Q4 2018 Feb 01, 2019	BUY	$39.11 - $75.15 $245,845 - $472,392	6,286 Added 183.69%	9,708 $407,000
Q3 2018 Nov 06, 2018	BUY	$65.0 - $82.15 $60,515 - $76,481	931 Added 37.37%	3,422 $258,000
Q2 2018 Aug 07, 2018	BUY	$27.2 - $74.35 $67,755 - $185,205	2,491 New	2,491 $179,000
Q1 2018 May 03, 2018	SELL	$24.05 - $37.5 $579,989 - $904,350	-24,116 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$26.0 - $34.6 $138,814 - $184,729	5,339 Added 28.43%	24,116 $802,000
Q3 2017 Nov 07, 2017	BUY	$18.0 - $32.95 $337,986 - $618,702	18,777	18,777 $619,000

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

45.4M

Call Options Held

184K

Put Options Held

56.7K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $314M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Regenxbio Inc. Transaction History